Brincidofovir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Brincidofovir
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Brincidofovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

PATENTS & EXCLUSIVITIES

6 US Patents, 2 US Exclusivities, 6 Health Canada Patents

6 US Patents
2 US Exclusivities
6 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Torys LLP

filter Patent Reset all filters

6 All

01 22779473

02 22809679

03 22929593

filter Product Reset all filters

6 All

01 6BRINCIDOFOVIR

filter Dosage Reset all filters

6 All

01 3SUSPENSION

02 3TABLET

filter Exp Date Reset all filters

6 All

01 22030-10-29

02 22031-08-31

03 22034-10-10

Product Main Page

01

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-29

Date Granted : 2016-08-16

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2779473

Filing Date : 2010-10-29

Strength per Unit : 10mg / mL

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-10-29

Date Granted : 2016-08-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-31

Date Granted : 2018-03-20

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2809679

Filing Date : 2011-08-31

Strength per Unit : 10mg / mL

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-08-31

Date Granted : 2018-03-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-10-10

Date Granted : 2020-03-10

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2929593

Filing Date : 2014-10-10

Strength per Unit : 10mg / mL

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-10-10

Date Granted : 2020-03-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-29

Date Granted : 2016-08-16

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2779473

Filing Date : 2010-10-29

Strength per Unit : 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-10-29

Date Granted : 2016-08-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-31

Date Granted : 2018-03-20

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2809679

Filing Date : 2011-08-31

Strength per Unit : 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-08-31

Date Granted : 2018-03-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Torys LLP

BRINCIDOFOVIR

iPHEX India

Not Confirmed

Torys LLP

Country

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-10-10

Date Granted : 2020-03-10

BRINCIDOFOVIR

Brand Name : TEMBEXA

Patent Number : 2929593

Filing Date : 2014-10-10

Strength per Unit : 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-10-10

Date Granted : 2020-03-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!